Sex effect on the correlation of immunoglobulin G glycosylation with rheumatoid arthritis disease activity

Rheumatoid arthritis (RA) is a chronic autoimmune disease which affects females more than males with a presence of autoantibodies. Immunoglobulin G (IgG) produced by adaptive arm has 2 functional domains, Fc and Fab. The Fc domain binds Fc gamma receptors and C1q proteins of the innate arm. Therefore, the IgG Fc domain serves as a bridge between the innate and adaptive arms and is regulated by an evolutionarily conserved N-glycosylation with variable structures. These glycans are classified as agalactosylated G0, monogalactosylated G1, and digalactosylated G2, which are further modified by core-fucosylation (F) and bisecting N-acetylglucosamine (B) moieties such as G0F and G0FB. Interestingly, proinflammatory G0F is shown to be regulated by estrogen in vivo. Here, it is hypothesized that the regulation of G0F by estrogen contributes to sex dichotomy in RA by setting up the level of IgG-dependent inflammation and therefore, RA disease activity (Das28-CRP3). To investigate this hypothesis, IgG glycosylation was characterized in serum samples from active RA patients (n = 232) and healthy controls (n = 232) by serum N-glycan analysis using the high performance liquid chromatography. According to the results, the IgG Fc glycan phenotype originates predominantly from the structure of G0F, and both G0F and G0FB correlate with Das28-CRP3 in females, but not in males. In conclusion, IgG G0F-dependent inflammation differs in males and females, and these differences point to the differential regulation of inflammation by sex hormone estrogen via IgG glycosylation.

Keywords:

IgG, glycosylation, sex, immune response inflammation,

PDF

___

Adamczyk B, 2017, METHODS MOL BIOL, V1503, P97, DOI 10.1007/978-1-4939-6493-2_8
Adamczyk B, 2013, J PROTEOME RES, V12, P444, DOI 10.1021/pr300813h
Ahmed AA, 2014, J MOL BIOL, V426, P3166, DOI 10.1016/j.jmb.2014.07.006
Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009
Allhorn M, 2010, BLOOD, V115, P5080, DOI 10.1182/blood-2009-08-239020
Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315
Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134
Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6
Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8
Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702
Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007
Atzeni F, 2017, ISR MED ASSOC J, V19, P512
Axford JS, 1999, BBA-MOL BASIS DIS, V1455, P219, DOI 10.1016/S0925-4439(99)00057-5
Biram A, 2019, IMMUNOL REV, V288, P37, DOI 10.1111/imr.12737
Bondt A, 2018, ANN RHEUM DIS, V77, P1130, DOI 10.1136/annrheumdis-2018-212946
Bondt A, 2013, J PROTEOME RES, V12, P4522, DOI 10.1021/pr400589m
Bournazos S, 2019, CURR TOP MICROBIOL, V423, P1, DOI 10.1007/82_2019_149
Bournazos S, 2017, INT IMMUNOL, V29, P303, DOI 10.1093/intimm/dxx025
De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804
Ditzel HJ, 2004, TRENDS MOL MED, V10, P40, DOI 10.1016/j.molmed.2003.11.004
Dolsen MR, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-0993-4
Engdahl C, 2018, ARTHRITIS RES THER, V20, P12674, DOI [10.1073/pnas.1108455108., DOI 10.1073/PNAS.1108455108]
Ercan A, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89703
Ercan A, 2010, ARTHRITIS RHEUM-US, V62, P2239, DOI 10.1002/art.27533
Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108
Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747
Golay J, 2013, BLOOD, V122, P3482, DOI 10.1182/blood-2013-05-504043
Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+
HASSFELD W, 1989, ARTHRITIS RHEUM, V32, P1515, DOI 10.1002/anr.1780321204
Holers V Michael, 2007, Curr Rheumatol Rep, V9, P396, DOI 10.1007/s11926-007-0063-5
Holland M, 2006, BBA-GEN SUBJECTS, V1760, P669, DOI 10.1016/j.bbagen.2005.11.021
Hueber W, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2706
Jay JW, 2018, ANTIBODIES, V7, DOI 10.3390/antib7020018
Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021
Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594
Klein SL, 2012, BIOESSAYS, V34, P1050, DOI 10.1002/bies.201200099
Klein SL, 2012, ENDOCRINOLOGY, V153, P2544, DOI 10.1210/en.2011-2120
Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X
Lood C, 2012, ARTHRITIS RHEUM-US, V64, P2698, DOI 10.1002/art.34454
LUND J, 1990, MOL IMMUNOL, V27, P1145, DOI 10.1016/0161-5890(90)90103-7
Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941
MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237
Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177
Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772
Matsuo K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2085
Monach PA, 2004, ADV IMMUNOL, V82, P217, DOI 10.1016/S0065-2776(04)82005-4
MONACH PA, 2008, CURR PROTOC IMMUNOL, V81, P1
Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581
Nandakumar KS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01623
Nandakumar KS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030677
Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004
Nicholson LB, 2016, ESSAYS BIOCHEM, V60, P275, DOI 10.1042/EBC20160017
Pagan JD, 2018, CELL, V172, P564, DOI 10.1016/j.cell.2017.11.041
Peschke B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00646
Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939
Quast I, 2017, CELL MOL LIFE SCI, V74, P837, DOI 10.1007/s00018-016-2366-z
Rainville JR, 2018, FRONT NEUROENDOCRIN, V50, P67, DOI 10.1016/j.yfrne.2017.12.004
Raju TS, 2014, CURR OPIN BIOTECH, V30, P147, DOI 10.1016/j.copbio.2014.06.014
Reiding KR, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00241
Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012
Royle Louise, 2006, V347, P125 .
Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046
Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578
Skriner K, 2006, ARTHRITIS RHEUM, V54, P3809, DOI 10.1002/art.22276
Smolen JS, 2016, LANCET, V388, P1984 .
Suan D, 2017, CURR OPIN IMMUNOL, V45, P97, DOI 10.1016/j.coi.2017.03.006
Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002
Tanaka-Watanabe Y, 2009, CLIN EXP IMMUNOL, V155, P285, DOI 10.1111/j.1365-2249.2008.03816.x
Taylor AI, 2009, BIOCHEMISTRY-US, V48, P558, DOI 10.1021/bi8019993
Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862
van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395
van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892
Verpoort KN, 2007, ARTHRITIS RHEUM, V56, P3949, DOI 10.1002/art.23127
Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520
Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149
Wang J, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010017-1, 10.1074/mcp.M111.010017, 10.1074/mcp.M110.004655]
Watson M, 1999, ARTHRITIS RHEUM, V42, P1682, DOI 10.1002/1529-0131(199908)42:8<1682::AID-ANR17>3.0.CO;2-X
WOZNICZKOORLOWSKA G, 1982, INT ARCH ALLER A IMM, V68, P28, DOI 10.1159/000233063
YOUNG BJJ, 1979, BRIT MED J, V2, P97, DOI 10.1136/bmj.2.6182.97